10 completed, 3 terminated, 2 withdrawn. 15 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 15 | Completed 10, Terminated 3, Withdrawn 2 |
| Phase 3 | 2 | Completed 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow anecortave acetate: new trials by email Literature Review of anecortave acetate trials Research Report on anecortave acetate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension Anecortave Acetate Sterile Suspension, 6 mg/mL, Anecortave Acetate Sterile Suspension, 3.75 mg/mL, Anecortave Acetate Sterile Suspension, 96 mg/mL - Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Terminated | Alcon Research | 197 | 2008-12-01 | 2012-11-30 |
| Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension Anecortave Acetate Sterile Suspension, 30 mg/mL, Anecortave Acetate Sterile Suspension, 60 mg/mL, Anecortave Acetate Sterile Suspension, 75 mg/mL - Open-angle Glaucoma, Oular Hypertension | Phase 2 / Phase 3 | Completed | Alcon Research | 201 | 2008-06-01 | 2012-11-28 |
| A Multi-Dose Study With a Treatment for Open-Angle Glaucoma Anecortave Acetate, Placebo - Open-Angle Glaucoma | Phase 2 / Phase 3 | Withdrawn | Alcon Research | 2008-05-01 | 2012-05-30 | |
| Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate Anecortave Acetate Sterile suspension 15 mg, Anecortave Acetate - Chronic Central Serous Chorioretinopathy | Phase 1 / Phase 2 | Completed | Manhattan Eye, Ear & Throat Hospital | 5 | 2007-05-01 | 2012-10-25 |
| Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma Anecortave Acetate Sterile Suspension, 30 mg/mL, Anecortave Acetate Vehicle - Open-angle Glaucoma | Phase 2 | Completed | Alcon Research | 89 | 2007-03-01 | 2012-11-28 |
| Anecortave Acetate in Patients With Open-angle Glaucoma Anecortave Acetate Sterile Suspension, 6 mg/mL, Anecortave Acetate Sterile Suspension, 30 mg/mL, Anecortave Acetate Sterile Suspension, 60 mg/mL - Open-angle Glaucoma | Phase 2 | Completed | Alcon Research | 86 | 2006-03-01 | 2012-11-28 |
| Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation Anecortave Acetate Sterile Suspension, 6 mg/mL, Anecortave Acetate Suspension Depot, 30 mg/mL, Anecortave Acetate Sterile Suspension, 60 mg/mL - Eye Diseases | Phase 2 | Completed | Alcon Research | 70 | 2005-12-01 | 2012-11-28 |
| Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg) Anecortave Acetate - Eye Injuries | Phase 2 | Terminated | Manhattan Eye, Ear & Throat Hospital | 2 | 2004-04-01 | 2007-06-21 |
| Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care. Anecortave Acetate - Age-Related Macular Degenerations., Subfoveal Neovascularization. | Phase 2 | Completed | Manhattan Eye, Ear & Throat Hospital | 5 | 2003-05-01 | 2007-05-07 |
| Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.) anecortave acetate - Coat's Disease | Phase 2 | Completed | Manhattan Eye, Ear & Throat Hospital | 4 | 2002-03-01 | 2012-10-24 |
| Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.) Anecortave Acetate - Retinal Vein Occlusion | Phase 2 | Withdrawn | Manhattan Eye, Ear & Throat Hospital | 2002-03-01 | 2009-02-04 | |
| Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.). anecortave acetate - Idiopathic Perifoveal Telangiectasia | Phase 2 | Completed | Manhattan Eye, Ear & Throat Hospital | 5 | 2002-03-01 | 2009-02-04 |
| Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.). anecortave acetate - Severe Diabetic Retinopathy, Central Retinal Vein Occlusion | Phase 2 | Terminated | Manhattan Eye, Ear & Throat Hospital | 2002-03-01 | 2007-05-07 | |
| Anecortave Acetate Versus Placebo in AMD Patients Following PDT anecortave acetate - AMD | Phase 2 | Completed | Alcon Research | 136 | 2000-05-01 | 2008-08-05 |
| A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration Anecortave acetate 30 mg, Anecortave Acetate 15 mg, Anecortave Acetate 3 mg - AMD | Phase 2 | Completed | Alcon Research | 128 | 1999-04-01 | 2012-03-06 |
Glaucoma, Open-Angle (5) · Glaucoma (2) · Retinal Vein Occlusion (2) · Communicable Diseases (1) · Diabetic Retinopathy (1) · Eye Diseases (1) · Eye Injuries (1) · Macular Degeneration (1) · Ocular Hypertension (1) · Retinal Telangiectasis (1)
Alcon Research (8) · Manhattan Eye, Ear & Throat Hospital (7)
United States (12) · Brazil (1) · Hungary (1) · Italy (1) · Netherlands (1) · Puerto Rico (1) · Spain (1) · United Kingdom (1)
Lawrence A. Yannuzzi, MD (6) · Theresa Landry (2) · Jason S. Slakter, MD (1) · Patricia Zilliox (1) · Theresa Landry, Ph.D. (1)
2005 (1)